Objective The aim of the current study was to evaluate quetiapine doses used across diagnosis categories in a sample of psychiatric inpatients. Methods Discharge letters of all adult inpatients who had received quetiapine between 1999 and 2005 were retrospectively reviewed. Logistic regressions were carried-out to assess links between quetiapine discharge dosage (≥800mg/day vs. <800mg/day), diagnostic categories, substance abuse or dependence, benzodiazepine discharge doses, age and sex. Results The data of 231 patients were included. Five hundred and for discharge documents were analyzed: 113 for psychotic disorders, 190 for personality disorders, 134 for bipolar and schizoaffective bipolar disorders, 29 for unipolar depression or anxiety ...
ABSTRACT Introduction: Case reports and poison center data have demonstrated that the second-ge...
This paper presents a preliminary examination of the use of quetiapine (an antipsychotic drug) among...
BACKGROUND: In controlled studies of patients with schizophrenia, the atypical antipsychotic quetiap...
OBJECTIVE: Although the maximal quetiapine doses in the published studies were restricted to 800 mg/...
AbstractObjectiveTo investigate the association between initial quetiapine dose and effectiveness as...
OBJECTIVE: To evaluate clinical outcomes and the tolerability of 2 weeks' quetiapine (QTP) treatment...
Ling Zhang, Gang Wang, Jiong Luo, Qing-E Zhang, Qian Zhao, Qi-Ying Deng, Xin Ma Mood Disorders Cente...
AbstractObjectiveTo investigate the association between initial quetiapine dose and effectiveness as...
The use of quetiapine for treatment of bipolar disorders at a higher dosage than the licensed range ...
Data on quetiapine overdosage are only sparsely available in the literature. This study provides add...
Data on quetiapine overdosage are only sparsely available in the literature. This study provides add...
Data on quetiapine overdosage are only sparsely available in the literature. This study provides add...
Data on quetiapine overdosage are only sparsely available in the literature. This study provides add...
International guidelines consider quetiapine at medium doses (300-400 mg/day) as valid options for t...
Data on quetiapine overdosage are only sparsely available in the literature. This study provides add...
ABSTRACT Introduction: Case reports and poison center data have demonstrated that the second-ge...
This paper presents a preliminary examination of the use of quetiapine (an antipsychotic drug) among...
BACKGROUND: In controlled studies of patients with schizophrenia, the atypical antipsychotic quetiap...
OBJECTIVE: Although the maximal quetiapine doses in the published studies were restricted to 800 mg/...
AbstractObjectiveTo investigate the association between initial quetiapine dose and effectiveness as...
OBJECTIVE: To evaluate clinical outcomes and the tolerability of 2 weeks' quetiapine (QTP) treatment...
Ling Zhang, Gang Wang, Jiong Luo, Qing-E Zhang, Qian Zhao, Qi-Ying Deng, Xin Ma Mood Disorders Cente...
AbstractObjectiveTo investigate the association between initial quetiapine dose and effectiveness as...
The use of quetiapine for treatment of bipolar disorders at a higher dosage than the licensed range ...
Data on quetiapine overdosage are only sparsely available in the literature. This study provides add...
Data on quetiapine overdosage are only sparsely available in the literature. This study provides add...
Data on quetiapine overdosage are only sparsely available in the literature. This study provides add...
Data on quetiapine overdosage are only sparsely available in the literature. This study provides add...
International guidelines consider quetiapine at medium doses (300-400 mg/day) as valid options for t...
Data on quetiapine overdosage are only sparsely available in the literature. This study provides add...
ABSTRACT Introduction: Case reports and poison center data have demonstrated that the second-ge...
This paper presents a preliminary examination of the use of quetiapine (an antipsychotic drug) among...
BACKGROUND: In controlled studies of patients with schizophrenia, the atypical antipsychotic quetiap...